相似文献/References:
[1]韦 莉,缪淑贤,王 敏,等.胰腺癌患者血清尿酸、肌酐水平检测及尿酸/肌酐比值的临床意义[J].现代检验医学杂志,2019,34(04):99.[doi:10.3969/j.issn.1671-7414.2019.04.024]
WEI Li,MIAO Shu-xian,WANG Min,et al.Clinical Significance of Serum Uric Acid,Creatinine
and Uric Acid/Creatinine Ratio in Pancreatic Ductal Adenocarcinoma[J].Journal of Modern Laboratory Medicine,2019,34(06):99.[doi:10.3969/j.issn.1671-7414.2019.04.024]
[2]邢瑞青,彭道荣,刘 杨.血清CA199,KL-6和PIVKA-Ⅱ水平联合检测在胰腺癌诊断中的应用价值分析[J].现代检验医学杂志,2021,36(05):100.[doi:10.3969/j.issn.1671-7414.2021.05.022]
XING Rui-qing,PENG Dao-rong,LIU Yang.Application Value of Combined Detection of Serum CA199,KL-6 andPIVKA -Ⅱ Levels in the Diagnosis of Patients with Pancreatic Cancer[J].Journal of Modern Laboratory Medicine,2021,36(06):100.[doi:10.3969/j.issn.1671-7414.2021.05.022]
[3]王东琴,霍浩然,秦瑞峰,等.胰腺癌患者血清 lncRNA-SNHG11的表达水平及其临床意义[J].现代检验医学杂志,2022,37(01):125.[doi:10.3969/j.issn.1671-7414.2022.01.025]
WANG Dong-qin,HUO Hao-ran,QIN Rui-feng,et al.Expression Level of Serum lncRNA-SNHG11 in Patients with Pancreatic Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2022,37(06):125.[doi:10.3969/j.issn.1671-7414.2022.01.025]
[4]王军堂a,齐普良a,张金刚a,等.hsa_circ_0006950 调控miR-124-3p/EZH2 轴促进胰腺癌细胞增殖与迁移的机制研究[J].现代检验医学杂志,2022,37(05):93.[doi:10.3969/j.issn.1671-7414.2022.05.019]
WANG Jun-tanga,QI Pu-lianga,ZHANG Jin-ganga,et al.Mechanism of hsa_circ_0006950 Regulating miR-124-3p /EZH2 Axis to Promote the Proliferation and Migration of Pancreatic Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(06):93.[doi:10.3969/j.issn.1671-7414.2022.05.019]
[5]张莉娜,张霁雯,罗 酩,等.胰腺癌组织CTTN 和miR-545-3p 表达水平及其与临床病理和预后的相关性研究[J].现代检验医学杂志,2022,37(06):99.[doi:10.3969/j.issn.1671-7414.2022.06.018]
ZHANG Li-na,ZHANG Ji-wen,LUO Ming,et al.Expression Levels of CTTN and miR-545-3p in Pancreatic Cancer Tissues and Their Correlation with Clinicopathology and Prognosis[J].Journal of Modern Laboratory Medicine,2022,37(06):99.[doi:10.3969/j.issn.1671-7414.2022.06.018]
[6]张立洁a,彭 泉b.基于GEO 数据库筛选慢性胰腺炎恶变过程中关键miRNA 和ceRNA 网络构建[J].现代检验医学杂志,2023,38(02):18.[doi:10.3969/j.issn.1671-7414.2023.02.004
]
ZHANG Li-jiea,PENG Quanb.Screening of Key miRNAs and Construction of Competing Endogenous RNA Network Involved in the Progression from Chronic Pancreatitis to Pancreatic Cancer Based on GEO Database[J].Journal of Modern Laboratory Medicine,2023,38(06):18.[doi:10.3969/j.issn.1671-7414.2023.02.004
]
[7]檀占海,陈建荣,张吉发,等.胰腺癌组织中METTL14 和GFPT1 的水平表达与临床预后价值研究[J].现代检验医学杂志,2023,38(05):99.[doi:10.3969/j.issn.1671-7414.2023.05.019]
TAN Zhanhai,CHEN Jianrong,ZHANG Jifa,et al.Expression of METTL14 and GFPT1 in Pancreatic Cancer and Their Clinical Prognostic Value[J].Journal of Modern Laboratory Medicine,2023,38(06):99.[doi:10.3969/j.issn.1671-7414.2023.05.019]
[8]夏菊芳,刘 洪.胰腺癌组织中KYNU mRNA 的表达及其与免疫浸润和预后的相关性研究[J].现代检验医学杂志,2024,39(02):57.[doi:10.3969/j.issn.1671-7414.2024.02.011]
XIA Jufang,LIU Hong.Expression of KYNU mRNA in Pancreatic Cancer Tissue and Its Correlation with Immune Infiltration and Prognosis[J].Journal of Modern Laboratory Medicine,2024,39(06):57.[doi:10.3969/j.issn.1671-7414.2024.02.011]